Long term follow-up of Polycythemia Vera patients treated with imatinib mesylate

被引:0
|
作者
Jones, C. Michael [1 ]
机构
[1] Jones Clin, Germantown, TN USA
关键词
Imatinib mesylate; Polycythemia Vera; Myeloproliferative disorder; Myeloproliferative neoplasm; Tyrosine kinase inhibitor; Myelosuppressive therapy;
D O I
10.1016/j.leukres.2012.03.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:815 / 816
页数:2
相关论文
共 50 条
  • [1] Imatinib mesylate in polycythemia vera
    Spivak, JL
    Silver, RT
    BLOOD, 2004, 103 (08) : 3241 - 3241
  • [2] Treatment of polycythemia vera with imatinib mesylate
    Silver, Richard T.
    Bourla, Michael H.
    Vandris, Katherine
    Fruchtman, Steven
    Spivak, Jerry L.
    Feldman, Eric J.
    Salvado, August J.
    LEUKEMIA RESEARCH, 2012, 36 (02) : 156 - 162
  • [3] Long-Term Follow-up in Interferon-Alpha Treated Polycythemia Vera Patients - a Single Center Analysis
    Jeryczynski, Georg
    Gisslinger, Bettina
    Krauth, Maria Theresa
    Schalling, Martin
    Gisslinger, Heinz
    BLOOD, 2015, 126 (23)
  • [4] Polycythemia vera responds to imatinib mesylate
    Jones, CM
    Dickinson, TM
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (03): : 149 - 152
  • [5] Imatinib mesylate therapy for patients (pts) with polycythemia vera (PV)
    Borthakur, G
    Kantarjian, H
    Verstovsek, S
    O'Brien, S
    Giles, F
    Koller, C
    Rios, MB
    Cortes, JE
    BLOOD, 2004, 104 (11) : 428A - 428A
  • [6] Imatinib mesylate inhibits autonomous erythropoiesis in patients with polycythemia vera in vitro
    Oehler, L
    Jaeger, E
    Alexander, ER
    Sillaber, C
    Gisslinger, H
    Geissler, K
    BLOOD, 2003, 102 (06) : 2240 - 2242
  • [7] USE OF FERROKINETICS IN THE FOLLOW-UP OF PATIENTS WITH POLYCYTHEMIA-VERA
    GARCIA, Y
    CALLEJAS, J
    HERNANDEZ, P
    HAEMATOLOGIA, 1988, 21 (01) : 41 - 46
  • [8] Development of polycythemia vera in a patient with chronic myeloid leukemia treated by imatinib mesylate.
    Najman, A
    Van Den Akker, J
    Portnoi, MF
    Chaumarel, I
    BLOOD, 2003, 102 (11) : 311B - 311B
  • [9] Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study
    Kirsten Merx
    Alice Fabarius
    Philipp Erben
    Martin Griesshammer
    Andreas Reiter
    Wolf-Karsten Hofmann
    Rüdiger Hehlmann
    Andreas Hochhaus
    Eva Lengfelder
    Annals of Hematology, 2013, 92 : 907 - 915
  • [10] Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study
    Merx, Kirsten
    Fabarius, Alice
    Erben, Philipp
    Griesshammer, Martin
    Reiter, Andreas
    Hofmann, Wolf-Karsten
    Hehlmann, Ruediger
    Hochhaus, Andreas
    Lengfelder, Eva
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 907 - 915